Atypical Multifocal Granular Cell Tumor with FLT3 Y842C Somatic Mutation: A case report and a review of the literature
DOI:
https://doi.org/10.62438/tunismed.v102i10.5172Keywords:
Case Report, Endoscopy, Immunohistochemistry, Next-Generation SequencingAbstract
Introduction. Granular cell tumors (GCT) are predominantly benign neoplasms composed by cells with abundant eosinophilic granular cytoplasm. Although the majority of GCTs exhibit a benign clinical course, a minority display cytological atypia and may exhibit aggressive, cancer-like behavior. Definitive evidence of malignancy in GCTs is reliably established only through the presence of metastasis. Addi- tionally, a subset of GCTs demonstrates a high rate of recurrence, underscoring the need for better prog- nostic markers. Therefore, it is crucial to identify molecular markers associated with aggressive behavior in GCTs. Molecular analysis may be particularly beneficial in cases exhibiting cytological atypia to in- form clinical outcome prognostication and guide therapeutic strategies.
Observation. In this case report, a 45-year-old female with multiple gastrointestinal GCTs is pre- sented. The patient did not have any genetic syndromes commonly associated with GCT, such as neu- rofibromatosis type 1, Noonan syndrome or LEOPARD syndrome. The tumors not only demonstrated nuclear atypia, but also harbored a unique FLT3 Y842C somatic alteration identified by next-genera- tion sequencing. The patient remains asymptomatic and under endoscopic surveillance two years after diagnosis and complete resection of the neoplasms.
Conclusion. We presented an exceedingly rare case of multifocal atypical GCT in an adult without any previously known genetic syndrome. A tumoral FLT3 Y842C point mutation not previously reported in GCT was discovered. Although the precise significance of this finding is uncertain, FLT3 Y842C has been cataloged as likely pathogenic in ClinVar. This report underscores the potential predictive utility of next-generation sequencing in the characterization ....(abstract truncated at 250 words)
Downloads
References
Nasser H, Ahmed Y, Szpunar SM, Kowalski PJ. Malignant granular cell tumor: a look
into the diagnostic criteria. Pathol Res Pract. 2011;207(3):164-8.
Stemm M, Suster D, Wakely PE, Jr., Suster S. Typical and Atypical Granular Cell Tumors
of Soft Tissue: A Clinicopathologic Study of 50 Patients. Am J Clin Pathol. 2017;148(2):161-6.
Movahed S, Amiri AJ, Kalkali AR. A case report of atypical granular cell tumor of bladder.
Int J Surg Case Rep. 2024;121:109980.
Warren SJ, Alomari AK. Utility of sequencing for ATP6AP1 and ATP6AP2 to distinguish between atypical granular cell tumor with junctional component and melanoma. J Cutan Pathol.
;50(11):1014-9.
Liu JP, Song LX, Xu ZY, Wu Y, Yao XC, Li M, et al. Case report: Giant atypical granular
cell tumor of the median nerve. Front Neurol. 2023;14:1221912.
Wei MZ, Yan ZJ, Jiang JH, Jia XL. Atypical granular cell tumor of the urinary bladder: A
case report. World J Clin Cases. 2021;9(28):8453-60.
Tufano A, Canale V, Di Lascio G, Coppola G, Flammia RS, Cristini C. Atypical granular
cell tumor of the urinary bladder: A case report and literature review. Urol Case Rep.
;38:101669.
Brunsgaard EK, Wallis L, Cody B, Cavanaugh K. Atypical granular cell tumor developing
within a tattoo. JAAD Case Rep. 2020;6(6):546-8.
Nakamura Y, Fujino T, Nagata K, Imamura T, Teramoto Y, Asami Y, et al. A Rare Case
of a Primary Cutaneous Desmoplastic Atypical Granular Cell Tumor. Am J Dermatopathol.
;39(4):e50-e3.
Oh KY, Kang KR, Yoon HJ, Lee JI, Hong SP, Hong SD. Atypical granular cell tumor in
the maxilla: The first report of primary intraosseous granular cell tumor. Head Neck.
;38(8):E2467-70.
Mahoney A, Garg A, Wolpowitz D, Mahalingam M. Atypical granular cell tumor-apropos
of a case with indeterminate malignant potential. Am J Dermatopathol. 2010;32(4):370-3.
Ayadi L, Khabir A, Fakhfakh I, Abdelmoula MH, Makni S, Sellami Boudawara T.
[Granular cell tumor]. Rev Stomatol Chir Maxillofac. 2008;109(3):158-62.
Fanburg-Smith JC, Meis-Kindblom JM, Fante R, Kindblom LG. Malignant granular cell
tumor of soft tissue: diagnostic criteria and clinicopathologic correlation. Am J Surg Pathol.
;22(7):779-94.
Schrader KA, Nelson TN, De Luca A, Huntsman DG, McGillivray BC. Multiple granular
cell tumors are an associated feature of LEOPARD syndrome caused by mutation in PTPN11.
Clin Genet. 2009;75(2):185-9.
Ramaswamy PV, Storm CA, Filiano JJ, Dinulos JG. Multiple granular cell tumors in a
child with Noonan syndrome. Pediatr Dermatol. 2010;27(2):209-11.
Pareja F, Brandes AH, Basili T, Selenica P, Geyer FC, Fan D, et al. Loss-of-function
mutations in ATP6AP1 and ATP6AP2 in granular cell tumors. Nat Commun. 2018;9(1):3533.
Wei L, Liu S, Conroy J, Wang J, Papanicolau-Sengos A, Glenn ST, et al. Whole-genome
sequencing of a malignant granular cell tumor with metabolic response to pazopanib. Cold
Spring Harb Mol Case Stud. 2015;1(1):a000380.
Kindler T, Breitenbuecher F, Kasper S, Estey E, Giles F, Feldman E, et al. Identification
of a novel activating mutation (Y842C) within the activation loop of FLT3 in patients with acute
myeloid leukemia (AML). Blood. 2005;105(1):335-40.
Cheng J, Qu L, Wang J, Cheng L, Wang Y. High expression of FLT3 is a risk factor in
leukemia. Mol Med Rep. 2018;17(2):2885-92.
AACR Project GENIE: Powering Precision Medicine through an International Consortium. Cancer Discov. 2017;7(8):818-31.
Additional Files
Published
Issue
Section
Categories
License
Copyright (c) 2024 La Tunisie Médicale

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.